Mannkind (MNKD) EPS (Basic) Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -7.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.72% |
| Dec 31, 2025 | 10.61% |
| Sep 30, 2025 | 35.72% |
| Jun 30, 2025 | 26.41% |
| Mar 31, 2025 | 33.89% |
| Dec 31, 2024 | 31.48% |
| Sep 30, 2024 | 58.74% |
| Jun 30, 2024 | 58.51% |
| Mar 31, 2024 | 40.95% |
| Dec 31, 2023 | 27.72% |
| Sep 30, 2023 | 30.06% |
| Jun 30, 2023 | 26.32% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -6.27% |
| Jun 30, 2022 | -16.26% |
| Mar 31, 2022 | -7.72% |
| Dec 31, 2021 | -22.39% |
| Sep 30, 2021 | 50.00% |
| Jun 30, 2021 | 4.35% |
| Mar 31, 2021 | 41.52% |
| Dec 31, 2020 | 24.61% |
| Sep 30, 2020 | 45.57% |
| Jun 30, 2020 | 47.72% |
| Mar 31, 2020 | 38.26% |
| Dec 31, 2019 | -28.56% |
| Sep 30, 2019 | -26.78% |
| Jun 30, 2019 | 40.36% |
| Mar 31, 2019 | 34.90% |
| Dec 31, 2018 | 55.04% |
| Sep 30, 2018 | 25.69% |
| Jun 30, 2018 | 23.69% |
| Mar 31, 2018 | -46.20% |
| Dec 31, 2017 | -45.98% |
| Sep 30, 2017 | -51.02% |
| Jun 30, 2017 | -22.59% |
| Mar 31, 2017 | -6.69% |
| Dec 31, 2016 | 76.52% |
| Sep 30, 2016 | 113.74% |
| Jun 30, 2016 | -27.29% |
| Mar 31, 2016 | -24.58% |
| Dec 31, 2015 | -42.10% |
| Sep 30, 2015 | -21.03% |
| Jun 30, 2015 | -16.11% |
| Mar 31, 2015 | 33.33% |
| Dec 31, 2014 | 33.06% |
| Sep 30, 2014 | 33.78% |
| Jun 30, 2014 | 19.92% |
| Mar 31, 2014 | 25.60% |
| Dec 31, 2013 | 21.44% |
| Sep 30, 2013 | 24.82% |
| Jun 30, 2013 | 24.38% |